1. Hypoxia-sensitive pathways in intestinal inflammation
- Author
-
Cormac T. Taylor and Eric Brown
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,Physiology ,Inflammation ,Hypoxia (medical) ,medicine.disease ,Inflammatory bowel disease ,3. Good health ,03 medical and health sciences ,030104 developmental biology ,Enzyme ,chemistry ,Antigen ,Gene expression ,medicine ,Cancer research ,medicine.symptom ,Intestinal Disorder ,Colitis - Abstract
Inflammatory bowel disease (IBD) is a common chronic intestinal disorder characterised by a loss of epithelial barrier function leading to the unregulated movement of luminal antigenic material into mucosal tissue with resultant inflammation. In IBD, multiple components of the inflammatory response lead to tissue hypoxia. Mucosal hypoxia leads to the inactivation of prolyl hydroxylase domain-containing (PHD) enzymes, which in turn leads to the stabilisation of the hypoxia-inducible factor (HIF), which induces the expression of barrier protective genes. Furthermore, pharmacological hydroxylase inhibition has been shown to be protective in colitis, at least in part through enhancing intestinal epithelial barrier function through HIF-1-dependent barrier-protective gene expression. Therefore, targeting hypoxia-sensitive pathways represents a new and promising therapeutic approach in IBD.
- Published
- 2017
- Full Text
- View/download PDF